|

PM8002 Clinical Trials

3 actively recruiting trials

▼ -1 trial since May 2026

Pipeline

Phase 2: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Biotheus Inc.3

Indications

  • Cancer3
  • Malignant Neoplasm1
  • Neuroendocrine Neoplasm1
  • Triple Negative Breast Cancer (TNBC)1
  • Breast Cancer1

Other3 trials

A Study of PM8002 in Combination With Chemotherapy in Patients With NEN
Phase 2
PM8002 in the Treatment of Patients With Advanced Solid Tumors
Phase 1/2
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.